Pharmaceutical

Pharmaceutical and life sciences companies operate in a highly regulated environment that is both data and document-intensive. However, the data are only valuable if they can be converted into beneficial business intelligence. Traditional, labor intensive approaches to patient record review and adverse drug event detection are costly, inconsistent and slow. As a result, it is very difficult to consistently identify adverse drug events before they become significant problems.